Prof. MUHSİN MURAT MUHİP HARPUTLUOĞLU

Publication Network

Articles 94

1. Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the turkish population: A multicenter study

Moral K., Harputluoğlu M., Özkumur G. F., Gavcar D., Erbay E., EREN F., et al.

Liver Transplantation , vol.Publish Ahead of Print, 2026 (SCI-Expanded, Scopus)

2. Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome

Ma A. T., Juanola A., Patidar K. R., Barone A., Incicco S., Kulkarni A. V., et al.

Clinical Gastroenterology and Hepatology , vol.24, no.4, pp.1079-1091, 2026 (SCI-Expanded, Scopus)

3. Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia

Takeuchi Y., Tateishi R., Obi S., Otsuka M., Mochizuki H., Jazag A., et al.

Hepatology International , vol.20, no.2, pp.373-383, 2026 (SCI-Expanded, Scopus)

4. De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes

DANIŞ N., DÖNGELLİ H., ÜNEK T., Bacakoğlu A., Turan İ., Karasu A. Z., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.37, no.4, pp.510-523, 2026 (SCI-Expanded, Scopus, TRDizin)

5. Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis

Adali G., Acar S., Harputluoğlu M., YILMAZ T. U., KARAKAYALI H., Istemihan Z., et al.

Clinical Transplantation , vol.40, no.1, 2026 (SCI-Expanded, Scopus)

6. Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study

Çalışkan A. R., Turan I., Vatansever S., Weninger J., Şamdancı E. T., AKATLI A. N., et al.

Biomedicines , vol.13, no.7, 2025 (SCI-Expanded, Scopus)

7. Artemisia absinthium (wormwood)–induced toxic hepatitis: First reported cases with contrasting clinical outcomes

KESER M. F., ATAYAN Y., HARPUTLUOĞLU M. M. M., SEÇKİN Y., ERDOĞAN M. A., DURU M.

Hepatology forum , 2025 (ESCI, Scopus, TRDizin)

8. Karaciğer transplantasyonu

HARPUTLUOĞLU M. M. M., SEÇKİN Y., SAĞLAM O.

Türkiye Klinikleri Tıp Bilimleri Dergisi , pp.94-102, 2025 (Scopus, TRDizin)

9. Liver Transplantation for Autoimmune Hepatitis: 20 Years of Tertiary Centre Experience.

Sağlam O., Muhip Harputluoğlu M. M. M., Bilgiç Y., Yılmaz S., Yağın F. H., Efe C.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.1, no.1, 2024 (SCI-Expanded, Scopus, TRDizin)

10. Mushroom Intoxication in Türkiye: A Nationwide Cohort Study Based on Demographic Trends, Seasonal Variations, and the Impact of Climate Change on Incidence.

Turan Gökçe D., Arı D., Ata N., Gökcan H., İdilman R., Ülgü M. M., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.36, no.1, pp.61-66, 2024 (SCI-Expanded, Scopus, TRDizin)

11. Liver Transplantation for Hepatocellular Carcinoma with Expanded Criteria: Malatya Experience

İNCE V., USTA S., CARR B. I., KUTLU R., DİKİLİTAŞ M., HARPUTLUOĞLU M. M. M., et al.

Journal of Inonu Liver Transplantation Institute , vol.2, no.2, pp.72-77, 2024 (Peer-Reviewed Journal)

12. Lymphedema in a patient with decompensated cirrhosis

Alizade E., HARPUTLUOĞLU M. M. M., ALİZADE A.

Annals of Innovation in Medicine , vol.2, 2024 (Peer-Reviewed Journal)

13. Ameliorative Effects of Larazotide Acetate on Intestinal Permeability and Bacterial Translocation in Acute Pancreatitis Model in Rats.

Karahan D., Harputluoglu M. M. M., Gul M., Gunduz A., Ozyalin F., İnceoğlu F., et al.

Digestive diseases and sciences , vol.69, pp.1242-1252, 2024 (SCI-Expanded, Scopus)

14. The Course of Endoscopic Treatment Success in Biliary Complications After Living Donor Liver Transplantation

ATAMAN E., HARPUTLUOGLU M., BILGIC Y., CAGIN Y. F., ERDOGAN M. A., KUTLU R., et al.

Medeniyet Medical Journal , vol.39, no.1, pp.33-38, 2024 (Scopus, TRDizin)

15. HBV viral load and tumor and non-tumor factors in patients with HBV-associated HCC.

Ataman E., Harputluoglu M. M. M., Carr B. I., Gozukara H. G., Ince V., Yilmaz S.

Hepatology forum , vol.5, no.2, pp.73-76, 2024 (ESCI, Scopus, TRDizin)

16. Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study.

Akarsu M., Dolu S., Harputluoglu M. M. M., Yilmaz S., Akyildiz M., Gencdal G., et al.

Hepatology forum , vol.5, no.1, pp.3-6, 2024 (ESCI, Scopus, TRDizin)

17. Outcomes of patients with primary sclerosing cholangitis after liver transplantation in a predominantly living donor liver transplant center

Harputluoğlu M. M. M., Çalğın M. Z., Ataman E., Kutlutürk K., Kutlu R., Yılmaz S.

Journal of Liver Transplantation , vol.12, pp.100186, 2023 (Peer-Reviewed Journal)

18. The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort.

Yaras S., Demir M., Barutcu S., Yildirim A. E., Gurel S., Ucbilek E., et al.

Hepatology forum , vol.4, no.3, pp.92-96, 2023 (ESCI, Scopus, TRDizin)

19. First year real life experience with tenofovir alafenamide fumarate: The pythagorean cohort

KARAŞAHİN Ö., KALKAN İ. A., DAL T., TOPLU S., HARPUTLUOĞLU M. M., METE A. O., et al.

Hepatology forum , vol.4, no.2, pp.61-68, 2023 (Scopus, TRDizin)

20. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome

Efe C., Kulkarni A. V., Terziroli Beretta-Piccoli B., Magro B., Friedrich Staettermayer A., Cengiz M., et al.

HEPATOLOGY , vol.76, no.6, pp.1576-1586, 2022 (SCI-Expanded, Scopus)

21. Endoscopic Treatment for Duodenal Variceal Bleeding

ATAMAN E., HARPUTLUOĞLU M. M. M., BİLGİÇ Y., SAĞLAM O., ORMAN İ.

AVES Publishing Co. , vol.1, 2022 (Peer-Reviewed Journal)

22. The effect of clinicopathologic findings of hepatocellular carcinoma on posttransplant survival: a multcenter cohort from TASL liver transplantation special interest group

Akyildiz M., Gencdal G., İNCE V., HARPUTLUOĞLU M. M. M., Bozkurt B., ZEYTÜNLÜ M., et al.

JOURNAL OF HEPATOLOGY , vol.77, 2022 (SCI-Expanded, Scopus)

23. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

Montano-Loza A. J., Ronca V., Ebadi M., Hansen B. E., Hirschfield G., Elwir S., et al.

JOURNAL OF HEPATOLOGY , vol.77, no.1, pp.84-97, 2022 (SCI-Expanded, Scopus)

24. Trends and causes of etiology in adult liver transplant patients: multicenter study

AKARSU M., Harputluoglu M., YILMAZ S., Gencdal G., Akyildiz M., Polat K. Y., et al.

JOURNAL OF HEPATOLOGY , vol.77, 2022 (SCI-Expanded, Scopus)

25. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study

GÖKCAN H., YAPALI S., Harputluoglu M., Ellik Z. M. L., Gokcen P., ADANIR H., et al.

JOURNAL OF HEPATOLOGY , vol.77, 2022 (SCI-Expanded, Scopus)

26. Letter to the editor: Liver transplantation following severe acute respiratory syndrome-coronavirus-2 vaccination-induced liver failure

Efe C., Harputluoglu M., KARADAĞ SOYLU N., YILMAZ S.

HEPATOLOGY , vol.75, no.6, pp.1669-1671, 2022 (SCI-Expanded, Scopus) Sustainable Development

27. Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis

Harputluoglu M. M. M., Caliskan A. R., Akbulut S.

World Journal of Transplantation , vol.12, no.3, pp.59-64, 2022 (Scopus) Sustainable Development

28. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

Efe C., Lammert C., Tascilar K., Dhanasekaran R., Ebik B., Higuera-de la Tijera F., et al.

LIVER INTERNATIONAL , vol.42, no.3, pp.607-614, 2022 (SCI-Expanded, Scopus) Sustainable Development

29. Clinical Results of Peroral Endoscopic Myotomy in Patients with Achalasia, Esophageal Diverticular Disease, and Refractory Gastroparesis: A Single-Center …

BİLGİÇ Y., ATAMAN E., ORMAN İ., SAĞLAM O., UZANULU M. F., ÇAĞIN Y. F., et al.

Diagnostik and interventional endoscopy , 2022 (Peer-Reviewed Journal)

30. Effects of larazotide acetate, a tight junction regulator, on the liver and intestinal damage in acute liver failure in rats

Caliskan A. R., GÜL M., YILMAZ İ., OTLU B., ÜREMİŞ N., ÜREMİŞ M. M., et al.

HUMAN & EXPERIMENTAL TOXICOLOGY , vol.40, no.12_SUPPL, 2021 (SCI-Expanded, Scopus)

31. Hepatitis B Before and After Hepatocellular Carcinoma

Harputluoglu M., Carr B.

JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.4, pp.1206-1210, 2021 (ESCI, Scopus) Sustainable Development

32. Diagnostic and therapeutic management algorithm for biliary complications in living liver donors.

YILMAZ S., AKBULUT A. S., Usta S., Ozsay O., ŞAHİN T. T., SARICI K. B., et al.

Transplant international : official journal of the European Society for Organ Transplantation , vol.34, no.11, pp.2226-2237, 2021 (SCI-Expanded, Scopus)

33. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT

YAPALI S., GÖKCAN H., Harputluoglu M., Ellik Z. M., AKARSU M., DURAK S., et al.

HEPATOLOGY , vol.74, 2021 (SCI-Expanded, Scopus) Sustainable Development

34. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT

ADANIR H., Etik D. O., YILDIRIM A. E., Mehdiyev S., YAPALI S., COŞAR A. M., et al.

HEPATOLOGY , vol.74, 2021 (SCI-Expanded, Scopus) Sustainable Development

35. Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

AKARSU M., Onem S., TURAN İ., Adali G., Akdogan M., Akyildiz M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.9, pp.712-719, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

36. Multicentre international evaluation of autoimmune hepatitis and liver transplantation: disease recurrence is associated with recipient features, type of immunosuppression and impaired outcomes

Montano-Loza A. J., Ronca V., Ebadi M., Hansen B., Hirschfield G., Elwir S., et al.

JOURNAL OF HEPATOLOGY , vol.75, 2021 (SCI-Expanded, Scopus) Sustainable Development

37. Covid-19 in Liver Transplant Recipients: A National Cohort

Kabacam G., TURAN İ., KIYICI M., Ellik Z. M., Dolu S., Dayangac M., et al.

JOURNAL OF HEPATOLOGY , vol.75, 2021 (SCI-Expanded, Scopus) Sustainable Development

38. Etiology of Cirrhosis in Turkey: A National Cohort Study

YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.

JOURNAL OF HEPATOLOGY , vol.75, 2021 (SCI-Expanded, Scopus)

39. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

Efe C., Dhanasekaran R., Lammert C., Ebik B., Higuera-de la Tijera F., Aloman C., et al.

HEPATOLOGY , vol.73, no.6, pp.2099-2109, 2021 (SCI-Expanded, Scopus) Sustainable Development

40. Therapeutic Effects of Plasmapheresis on Acute Exacerbations of Chronic Hepatitis B Infection

BİLGİÇ Y., AKBULUT A. S., NURANSOY CENGİZ A., SARICI A., Cagin Y. F., Harputluoglu M.

CUREUS , vol.13, no.1, 2021 (ESCI) Sustainable Development

41. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.

Değertekin B., Demir M., Akarca U. S., Kani H. T., Üçbilek E., Yıldırım E., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.31, no.12, pp.883-893, 2020 (SCI-Expanded, Scopus, TRDizin)

42. Endoscopic treatment of biliary complications in donors after living donor liver transplantation in a high volume transplant center

ERDOĞAN M. A., Cagin Y. F., Atayan Y., BİLGİÇ Y., YILDIRIM O., ÇALIŞKAN A. R., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.9, pp.614-619, 2020 (SCI-Expanded, Scopus, TRDizin)

43. Author Correction: Liver Transplantation for Hepatocellular Carcinoma: Malatya Experience and Proposals for Expanded Criteria.

Ince V., Akbulut S., Otan E., Ersan V., Karakas S., Sahin T., et al.

Journal of gastrointestinal cancer , vol.51, no.3, pp.1006, 2020 (ESCI, Scopus)

44. Liver Transplantation for Hepatocellular Carcinoma: Malatya Experience and Proposals for Expanded Criteria.

Ince V., Akbulut A. S., Otan E., Ersan V., Karakas S., Sahin T. T., et al.

Journal of gastrointestinal cancer , vol.51, no.3, pp.998-1005, 2020 (ESCI, Scopus)

45. Endoscopic treatment of biliary complications after duct-to-duct biliary anastomosis in pediatric liver transplantation

Harputluoglu M. M. M., Demirel U., Caliskan A. R., Selimoglu A., Bilgic Y., Aladag M., et al.

LANGENBECKS ARCHIVES OF SURGERY , vol.404, no.7, pp.875-883, 2019 (SCI-Expanded, Scopus)

46. Acute liver failure in adults.

ÇALIŞKAN A. R., Harputluoglu M. M. M.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.30, no.10, pp.938-939, 2019 (SCI-Expanded, Scopus, TRDizin)

47. The risk factors of portal vein thrombosis in patients with liver cirrhosis

Cagin Y. F., BİLGİÇ Y., Berber İ., YILDIRIM O., ERDOĞAN M. A., Firat F., et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.17, no.4, pp.3189-3194, 2019 (SCI-Expanded)

48. Relationship between nucleotide-binding oligomerization domain-containing protein 2 variants and severity of acute pancreatitis.

Harputluoglu M. M. M., Ozbek M., Demirel U., Otlu B., Yener O., Gursoy N. C., et al.

Acta gastro-enterologica Belgica , vol.82, no.2, pp.285-290, 2019 (SCI-Expanded, Scopus)

49. Tedavi Başarısızlığı Olan Kronik HBV Hastalarında Nükleoz(t)idDirenç Mutasyonları

GÜRSOY N. C., OTLU B., YAKUPOĞULLARI Y., Yener Ö., BAYINDIR Y., HARPUTLUOĞLU M. M. M., et al.

Türk Mikrobiyoloji Cemiyeti Dergisi , vol.49, no.1, pp.41-46, 2019 (TRDizin)

50. Nucleos(t)ide Resistance Mutations in Chronic HBV Patients with Treatment Failure

GÜRSOY N. C., OTLU B., YAKUPOĞULLARI Y., Yener Ö., BAYINDIR Y., HARPUTLUOĞLU M. M. M., et al.

Türk Mikrobiyoloji Cemiyeti Dergisi , vol.49, no.1, pp.41-46, 2019 (TRDizin)

51. A mitochondrial neurogastrointestinal encephalomyopathy with intestinal pseudo-obstruction resulted from a novel splice site mutation

Erdogan M. A., SEÇKİN Y., HARPUTLUOĞLU M. M. M., KARINCAOĞLU M., ALADAĞ M., ÇALIŞKAN A. R., et al.

CLINICAL DYSMORPHOLOGY , vol.28, no.1, pp.22-25, 2019 (SCI-Expanded, Scopus)

52. Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient

Akbulut S., Harputluoglu M., Yilmaz S.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.16, no.5, pp.635-637, 2018 (SCI-Expanded, Scopus) Sustainable Development

53. Endoscopic treatment of biliary complications after living donor liver transplantation in a high volume transplant center in Turkey; a single-center experience

Harputluoglu M. M. M., Aladag M., Demirel U., Bilgic Y., Dertli R., Erdogan M. A., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.81, no.2, pp.283-287, 2018 (SCI-Expanded)

54. Stomach metastasis of malignant melanoma

BİLGİÇ Y., HARPUTLUOĞLU M. M. M., CAGIN Y. F., DİKİLİTAŞ M., AKATLI A. N., MEHRELİYEV e., et al.

annals of medical resaarch , 2018 (Peer-Reviewed Journal)

55. Endoscopic treatment of biliary complications in left lobe living donor liver transplantation

ERDOĞAN M. A., HARPUTLUOĞLU M. M. M.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.14, pp.2051-2056, 2018 (SCI-Expanded, Scopus)

56. Drug induced autoimmune hepatitis: A Single Center Experience

BİLGİÇ Y., HARPUTLUOĞLU H., YILMAZ C., KARADAĞ N., ÇAĞIN Y. F., AKBULUT A. S., et al.

BİOMEDİCAL RESEARCH-INDİA , vol.28, no.15, pp.6528-6532, 2017 (SCI-Expanded) Sustainable Development

57. Methylprednisolone prevents bacterial translocation in thioacetamide-induced liver failure in rats

HARPUTLUOĞLU M. M. M., Temel I., Demirel U., SEÇKİN Y., ALADAĞ M., OTLU B., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.28, no.5, pp.394-400, 2017 (SCI-Expanded, Scopus, TRDizin)

58. Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report

BİLGİÇ Y., Yilmaz C., Cagin Y. F., Atayan Y., KARADAĞ SOYLU N., HARPUTLUOĞLU M. M. M.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.80, no.2, pp.309-311, 2017 (SCI-Expanded, Scopus) Sustainable Development

59. NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis Reply

HARPUTLUOĞLU M. M. M., BİLGİÇ Y., ERDOĞAN M. A., ATAYAN Y., CAGIN Y. F., DERTLI R., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.61, no.7, pp.2143-2144, 2016 (SCI-Expanded, Scopus)

60. Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis

HARPUTLUOĞLU M. M. M., DERTLI R., OTLU B., Demirel U., YENER O., BİLGİÇ Y., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.61, no.6, pp.1545-1552, 2016 (SCI-Expanded, Scopus)

61. Liver Transplant in Patients with Viral Hepatitis and Human Immunodeficiency Virus Coinfection: The First 2 Cases in Turkey.

Ince V., Ozdemir F., Bayindir Y., Toprak H. İ., Harputluoglu M. M. M., Kutlu R., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , 2016 (SCI-Expanded, Scopus) Sustainable Development

62. Lighter Ingestion as an Uncommon Cause of Severe Vomiting in a Schizophrenia Patient

ATAYAN Y., CAGIN Y. F., ERDOĞAN M. A., BİLGİÇ Y., BESTAS R., Harputluoglu M. M. M., et al.

CASE REPORTS IN GASTROINTESTINAL MEDICINE , vol.2016, 2016 (ESCI)

63. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

BİLGİÇ Y., AKBULUT A. S., KUTLU O., ÇOLAK C., YILMAZ C., SEÇKİN Y., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.9, no.7, pp.13918-13925, 2016 (SCI-Expanded)

64. An overlooked perforated appendicitis presenting with anal pus discharge Anal pu akintisi olup tanisi atlanmis perfore apendisit vakasi

Bilgic Y., Kum A., Cagin Y. F., Seckin Y., Harputluoglu M. M. M., Yaprak B., et al.

Ann Med Res , vol.23, no.3, pp.336-338, 2016 (TRDizin)

65. Effects of Lycium barbarum on bacterial translocation in thioacetamide-induced liver injury in rats

BİLGİÇ Y., HARPUTLUOĞLU M. M. M., KUTLU O., Demirel U., GÜL M., OTLU B., et al.

EUROPEAN JOURNAL OF INFLAMMATION , vol.13, no.3, pp.154-163, 2015 (SCI-Expanded, Scopus)

66. Steatohepatitis Coexisting with Dubin Johnson Syndrome A Case Report

ERDOĞAN M. A., ATAYAN Y., ÇAĞIN Y. F., BİLGİÇ Y., ALADAĞ M., HARPUTLUOĞLU M. M. M., et al.

Medicine Science International Medical Journal , pp.1, 2015 (TRDizin)

67. The First Finding of Cirrhosis Hepatic Hydrothorax Caused by Absence of Ascites

ATAYAN Y., ERDOĞAN M. A., ÇAĞIN Y. F., BİLGİÇ Y., ALADAĞ M., HARPUTLUOĞLU M. M. M., et al.

Medicine Science , 2015 (TRDizin)

68. The Relationship Between Hepatic Activity Index and Serum Tumor Necrosis Factor Alpha Levels in Patients with Chronic Active Hepatitis B and Chronic Active Hepatitis C

BİLGİÇ Y., HARPUTLUOĞLU M. M. M., YAPRAK B., DAL M. B., BOZAN M. B., ŞAHİN A., et al.

Medicine Science | International Medical Journal , pp.1, 2015 (TRDizin) Sustainable Development

69. Ecstasy induced acute hepatic failure. Case reports

ATAYAN Y., CAGIN Y. F., ERDOĞAN M. A., HARPUTLUOĞLU M. M. M., BİLGİÇ Y.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.78, no.1, pp.53-55, 2015 (SCI-Expanded) Sustainable Development

70. Acute fatty liver of pregnancy disease developing in the early period

ATAYAN Y., ÇAĞIN Y. F., ERDOĞAN M. A., ALADAĞ M., KARINCAOĞLU M., HARPUTLUOĞLU M. M. M., et al.

Journal of Turgut Ozal Medical Center , 2014 (TRDizin)

71. Single-center analysis of the first 304 living-donor liver transplantations in 3 years.

YILMAZ S., KAYAALP C., ARA C., YILMAZ M., IŞIK B., AYDIN C., et al.

Hepato-gastroenterology , vol.60, no.125, pp.1105-9, 2013 (SCI-Expanded, Scopus) Sustainable Development

72. Effects of Rifaximin on Bacterial Translocation in Thioacetamide-Induced Liver Injury in Rats

HARPUTLUOĞLU M. M. M., Demirel U., GÜL M., TEMEL I., GURSOY S., SELÇUK E. B., et al.

INFLAMMATION , vol.35, no.4, pp.1512-1517, 2012 (SCI-Expanded, Scopus)

73. The effects of Teucrium polium on ionizing radiation-induced intestinal damage in rats

Demirel U., HARPUTLUOĞLU M. M. M., US S. B., KAYA E., SAHIN N., AYDIN N. E., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.74, no.4, pp.491-496, 2011 (SCI-Expanded, Scopus)

74. An Uncommon Presentation in Behcet's Disease: Recovered Descending-Colon Perforation with Conservative Medical Therapy: Case Report

Demirel U., HARPUTLUOĞLU M. M. M., Yagmur M., SEÇKİN Y., IŞIK B., ALADAĞ M.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.31, no.5, pp.1310-1312, 2011 (SCI-Expanded, Scopus)

75. An antibody of TNF-alpha did not prevent thioacetamide-induced hepatotoxicity in rats

DEMİREL U., HARPUTLUOĞLU M. M. M., SEÇKİN Y., ÇIRALIK H., Temel I., Ozyalin F., et al.

HUMAN & EXPERIMENTAL TOXICOLOGY , vol.30, no.7, pp.560-566, 2011 (SCI-Expanded, Scopus)

76. Hypovolemia-related gastric tissue damage in the setting of upper gastrointestinal bleeding.

KARINCAOĞLU M., Seckin Y., Ates F., Harputluoglu M. M. M., BATÇIOĞLU K., Yigit I. P., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.21, no.1, pp.17-22, 2010 (SCI-Expanded, Scopus, TRDizin)

77. Expression of claudin-4 and beta-catenin in gastric premalignant lesions.

Seckin Y., Arici S., Harputluoglu M. M. M., Yonem O., Yimaz A., Ozer H., et al.

Acta gastro-enterologica Belgica , vol.72, no.4, pp.407-12, 2009 (SCI-Expanded, Scopus)

78. Severe hepatitis with prolonged cholestasis and bile duct injury due the long-term use of ornidazole

Harputluoglu M. M. M., DEMIREL U., KARADAG N., KARAHAN D., ALADAG M., KARINCAOGLU M., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.70, no.3, pp.293-295, 2007 (SCI-Expanded, Scopus) Sustainable Development

79. Epicardial adipose tissue, hepatic steatosis and obesity.

Cikim A. S., Topal E., Harputluoglu M. M. M., Keskin L., Zengin Z., Cikim K., et al.

Journal of endocrinological investigation , vol.30, no.6, pp.459-64, 2007 (SCI-Expanded, Scopus) Sustainable Development

80. Pancreatic pseudocyst development due to organophosphate poisoning

HARPUTLUOĞLU M. M. M., DEMIREL U., ALAN H., ATES F., ALADAĞ M., KARINCAOĞLU M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.18, no.2, pp.122-125, 2007 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

81. Gastric tissue oxidative changes in portal hypertension and cirrhosis.

Seckin Y., HARPUTLUOGLU M. M. M., Batcioglu K., Karincaoglu M., YILDIRIM B., ONER R. I., et al.

Digestive diseases and sciences , vol.52, no.5, pp.1154-8, 2007 (SCI-Expanded, Scopus)

82. Protective effects of Gingko biloba on thioacetamide-induced fulminant hepatic failure in rats

Harputluoglu M. M. M., DEMIREL U., CIRALIK H., TEMEL I., FIRAT S., ARA C., et al.

HUMAN & EXPERIMENTAL TOXICOLOGY , vol.25, no.12, pp.705-713, 2006 (SCI-Expanded, Scopus)

83. The relationship of heart rate variability with severity and prognosis of cirrhosis

Ates F., Topal E., Kosar F., KARINCAOĞLU M., Yildirim B., Aksoy Y., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.51, no.9, pp.1614-1618, 2006 (SCI-Expanded, Scopus)

84. The effects of Gingko biloba extract on acetic acid-induced colitis in rats.

Harputluoglu M. M. M., Demirel U., Yücel N., Karadağ N., Temel I., Firat S., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.17, pp.177-82, 2006 (SCI-Expanded, Scopus, TRDizin)

85. The effects of Gingko biloba, vitamin E and melatonin on bacterial translocation in thioacetamide-induced fulminant hepatic failure in rats.

Harputluoglu M. M. M., Demirel U., Karadag N., Temel I., Bayraktar M., Firat S., et al.

Acta gastro-enterologica Belgica , vol.69, no.3, pp.268-75, 2006 (SCI-Expanded, Scopus)

86. Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population.

Aladağ M., Kantarçeken B., Karincaoğlu M., Sertkaya A., Cikim K., Harputluoğlu M. M. M., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.16, pp.242-3, 2005 (SCI-Expanded, Scopus, TRDizin)

87. Protective effect of resveratrol against oxidative stress in cholestasis

Ara C., Kirimlioglu H., Karabulut A., Coban S., Ay S., Harputluoglu M. M. M., et al.

JOURNAL OF SURGICAL RESEARCH , vol.127, no.2, pp.112-117, 2005 (SCI-Expanded, Scopus)

88. Spontaneous bacterial peritonitis due to Brucella Melitensis in a cirrhotic patient.

Kantarçeken B., Harputluoğlu M. M. M., Bayindir Y., Bayraktar M. R., Aladağ M., Hilmioğlu F.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.16, pp.38-40, 2005 (SCI-Expanded, Scopus, TRDizin)

89. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori

Mehmet N., Refik M., Harputluoglu M. M. M., Ersoy Y., Aydin N., Yildirim B.

MICROBIOLOGICA , vol.27, no.2, pp.139-148, 2004 (SCI-Expanded, Scopus) Sustainable Development

90. Two findings of portal hypertension: evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis.

Demirel U., Karincaoğlu M., Harputluoğlu M. M. M., Ateş M., Seçkin Y., Yildirim B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.14, pp.219-22, 2003 (SCI-Expanded, Scopus, TRDizin)

91. Acute pancreatitis: an obscure complication of organophosphate intoxication

Harputluoglu M. M. M., KANTARCEKEN B., KARINCAOGLU M., ALADAĞ M., YILDIZ R., ATES M., et al.

HUMAN & EXPERIMENTAL TOXICOLOGY , vol.22, no.6, pp.341-343, 2003 (SCI-Expanded, Scopus)

92. Autoimmune haemolytic anaemia and thrombocytopenia associated with ciprofloxacin

Aydogdu I., Ozerol I., Tayfun E., Harputluoglu M. M. M.

CLINICAL AND LABORATORY HAEMATOLOGY , vol.19, no.3, pp.223, 1997 (SCI-Expanded, Scopus)

93. Late relapse in a patient with acute lymphoblastic leukemia thirteen years after diagnosis

Aydogdu I., Tayfun E., Ozcan C., Harputluoglu M. M. M., Ozen S., Hicsonmez G.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.14, no.5, pp.491-493, 1997 (SCI-Expanded, Scopus)

94. Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia

Aydogdu I., Ozcan C., Harputluoglu M. M. M., Karincaoglu Y., Turhan O., Ozcanu A.

ANTI-CANCER DRUGS , vol.8, no.5, pp.468-469, 1997 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 173

1. PS-087 Acı Yavşan (Artemisia absinthium) ve Toksik Hepatit: Karşıt Klinik Seyir Gösteren İki Olgu

KESER M. F., ATAYAN Y., HARPUTLUOĞLU M. M. M., SEÇKİN Y., ERDOĞAN M. A.

42.ULUSAL GASTROENTEROLOJİ KONGRESİ, ANTALYA ps 087, Antalya, Turkey, 25 - 29 November 2025, (Full Text)

2. İleri Yaşta Kabakulak Enfeksiyonu: Hepatit ve Akalkülöz Kolesistit ile Seyreden Nadir Bir Olgu

KESER M. F., ATAYAN Y., keser z. b., SEÇKİN Y., HARPUTLUOĞLU M. M. M., ERDOĞAN M. A.

42.ULUSAL GASTROENTEROLOJİ KONGRESİ, ANTALYA, Antalya, Turkey, 25 November 2025, (Full Text)

3. Doğu Anadolu’da İlk Defa Görülen Akut Hepatit Etkeni; Tatarcık Humması, Deprem Sonrası Bölgede Vektör Ortaya Çıkmış Olabilir mi?

KESER M. F., ATAYAN Y., keser z. b., ERDOĞAN M. A., SEÇKİN Y., ÇAĞIN Y. F., et al.

42. ulusal gastroenteroloji hastası antalya 2025, Antalya, Turkey, 25 November 2025, (Full Text)

4. Long-term results of patients undergoing liver transplantation due to celiac disease

HARPUTLUOĞLU M. M. M.

APASL 2025, PEKİN, China, 26 - 30 March 2025, (Full Text)

5. Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry. Journal of Hepatology, 2024, 80: S336.

ADALI G., HARPUTLUOĞLU M. M. M.

easl 2024, 01 May 2024, pp.226, (Full Text)

6. Liver transplantation indications

HARPUTLUOĞLU M. M. M.

20. Uluslararası Avrasya Hepato Gastroenteroloji ve Cerrahi Kongresi & 20. Hepato Gastroenteroloji Kongresi, Baku, Azerbaijan, 25 - 27 April 2024, (Full Text)

7. Outcomes of patients with primary sclerosing cholangitis after liver transplantation in a predominantly living donor liver transplant center

Harputluoğlu M. M. M.

APASL 2024 33 TH ASIA PASIFIC LIVER CONGRESS, Kyoto, Japan, 27 - 31 March 2024, pp.312, (Full Text)

8. Outcomes of patients with primary sclerosing cholangitis after liver transplantation

HARPUTLUOĞLU M. M. M., ÇALGIN M. Z., YILMAZ S.

APASL 2024 Kyoto The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver, Kyoto, Japan, 27 - 31 March 2024, (Full Text)

9. Evaluation of data from the A-HOC (APASL Hepatology/Oncology Consortium) study of patients with hepatocellular cancer in Turkey

HARPUTLUOĞLU M. M. M.

APASL 2024 Kyoto The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver, Kyoto, Japan, 27 - 31 March 2024, (Full Text)

10. Liver Transplantation In Patients With Hepatitis B And Hepatocellular Carcinoma

HARPUTLUOĞLU M. M. M.

APASL 2024 Kyoto The 33rd Annual Meeting the Asian Pacific Association for the Study of the Liver, Kyoto, Japan, 27 - 31 March 2024, (Full Text)

11. PANKREATİK STENT UYGULAMASI İLE TRAVMA SONRASI PANKREAS FİSTÜLÜNÜN BAŞARIYLA TEDAVİSİ

KILCI M. B., BARUT B., HARPUTLUOĞLU M. M. M.

INTERNATIONAL HARRAN HEALTH SCIENCES CONGRESS-IV, 09 November 2022, (Summary Text)

12. Pandemi Süreci Kronik Hepatit B Hastalarının İzlemini Etkiledi Mi? Değişen HBV-DNA ve HBV İlaç Direnç Test Sayıları

TANRİVERDİ E. S., YAKUPOĞULLARI Y., BAYINDIR Y., HARPUTLUOĞLU M. M. M., OTLU B.

15. Ulusal Viral Hepatit Kongresi, Turkey, 07 October 2021, (Summary Text) Sustainable Development

13. Hepatit B Yüzey Antijeni Pozitif Hastalarda HDV-RNA Sıklığı: Tek Merkez Verileri

TANRİVERDİ E. S., YAKUPOĞULLARI Y., HARPUTLUOĞLU M. M. M., BAYINDIR Y., OTLU B.

15. Ulusal Viral Hepatit Kongresi, Turkey, 07 October 2021, (Summary Text) Sustainable Development

14. Larazotide acetate reduces the frequency of bacterial translocation in the thioacetamide-induced liver failure in rats

ÇALIŞKAN A. R., HARPUTLUOĞLU M. M. M., OTLU B., GÜL M., GÜREL E., ÜREMİŞ N., et al.

EASL: The Digital International Liver Congress, 27 - 29 August 2020, (Summary Text)

15. Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience

TURAN İ., ALADAĞ M., HARPUTLUOĞLU M. M. M., YILMAZ S., GENÇDAL G., POLAT K. Y., et al.

The Digital International Liver Congress (EASL) 2020, 27 - 29 August 2020, vol.73, pp.227, (Summary Text)

16. PERFORE APANDİSİT SONRASI GELİŞEN ABSE VE KOLONA FİSTÜLİZE OLGU SUNUMU

BİLGİÇ Y., KUM A., ÇAĞIN Y. F., HARPUTLUOĞLU M. M. M., ALADAĞ M., SEÇKİN Y., et al.

32. Ulusal gastroenteroloji haftası, Antalya, Turkey, 25 November 2015 - 29 November 2019, (Full Text)

17. KRONİK HEPATİT B VE C’xxLİ HASTALARDA TÜMÖR NEKROTİZAN FAKTÖR ALFA NIN KİNETİĞİ

BİLGİÇ Y., ÇAĞIN Y. F., SEÇKİN Y., HARPUTLUOĞLU M. M. M., ALADAĞ M., KARINCAOĞLU M., et al.

32.Ulusal gastroenteroloji haftası, Antalya, Turkey, 25 November 2015 - 29 November 2019, (Full Text)

18. Gaucher disease associated with gallstone disease Two cases

ALADAĞ M., ERDOĞAN M. A., ÇAĞIN Y. F., BİLGİÇ Y., YILDIRIM O., HARPUTLUOĞLU M. M. M., et al.

Gaucher symposium 2018, İstanbul, Turkey, 21 - 22 October 2018, (Summary Text)

19. Rare association, Gaucher’xxs disease and SLE: Due to a case.

ALADAĞ M., ALADAĞ H., ERDOĞAN M. A., ÇALIŞKAN A. R., CAGIN Y. F., BİLGİÇ Y., et al.

APASL single topic conference, 27 - 29 September 2018, (Full Text)

20. Denovo Crohn disease after liver transplantation a case

ALADAĞ M., ERDOĞAN M. A., YILDIRIM O., BİLGİÇ Y., ÇAĞIN Y. F., HARPUTLUOĞLU M. M. M., et al.

APASL single topic conference, İstanbul, Turkey, 27 - 29 September 2018, (Summary Text)

21. Efficacy and safety of Ombitasvir, dasabuvir and paritaprevir in cirrhotic cases secondary to HCV

ALADAĞ M., ERDOĞAN M. A., BİLGİÇ Y., YILDIRIM O., ÇAĞIN Y. F., HARPUTLUOĞLU M. M. M., et al.

APASL Single topic conference, İstanbul, Turkey, 27 - 29 September 2018, (Summary Text)

22. Sirotik hastalarda beslenmenin önemi

HARPUTLUOĞLU M. M. M.

15.Anadolu Gastroenteroloji Günleri Sivas, Turkey, 14 - 15 September 2018, (Full Text)

23. Endoscopic results pediatric patiens liver transplataion

HARPUTLUOĞLU M. M. M., ALADAĞ M., BİLGİÇ Y., ERDOĞAN M. A., YILMAZ S.

The 2018 joint international of congress ILTS ELITA, 23 - 26 June 2018, (Full Text)

24. Successful management of de novo acute hepatitis B with entecavir in a patient underwent living donor liver transplantation

Akbulut A. S., Harputluoğlu M. M. M., Yılmaz S.

The 2018 Joint International Congress of ILTS, ELITA & LICAGE, Lisbon, Portugal, 23 - 26 May 2018, vol.102, pp.334, (Summary Text)

25. Endoscopic treatment of biliary complication after pediatric liver transplantation in a high volume transplant center

HARPUTLUOĞLU M. M. M., ALADAĞ M., BİLGİÇ Y., ERDOĞAN M. A., ÇALIŞKAN A. R., SELİMOĞLU A., et al.

ILTS, 23 - 26 May 2018, (Full Text)

26. Mitokondriyal nöro-gastrointestinal ensefalomiyopati: nadir bir oldu sunumu

ERDOĞAN M. A., SEÇKİN Y., HARPUTLUOĞLU M. M. M., KARINCAOĞLU M., ALADAĞ M., ÇALIŞKAN A. R., et al.

1. İnönü İç Hastalıkları kongresi, Malatya, Turkey, 27 - 28 April 2018, (Full Text)

27. Ten years efficacy of Entecavir and PEG INF combinations therapy on HBsAg loss and seroconversion in patients with chronic HBV

ALADAĞ M., ERDOĞAN M. A., BİLGİÇ Y., YILDIRIM O., ÇAĞIN Y. F., HARPUTLUOĞLU M. M. M., et al.

TASL-EASL Educational conference, 2 - 04 March 2018, (Summary Text)

28. Enzyme replacement therapy for Gaucher disease during pregnancy: A case report

ALADAĞ M., ERDOĞAN M. A., BİLGİÇ Y., YILDIRIM O., ÇAĞIN Y. F., HARPUTLUOĞLU M. M. M., et al.

TASL-EASL Educational Confcerence, 2 - 04 March 2018, (Summary Text)

29. Breast cancer after Sofosbuvir/ledipasvir therapy, two cases

ALADAĞ M., ERDOĞAN M. A., BİLGİÇ Y., YILDIRIM O., ÇAĞIN Y. F., HARPUTLUOĞLU M. M. M., et al.

TASL-EASL Educational conference, İstanbul, Turkey, 2 - 04 March 2018, (Summary Text) Sustainable Development

30. KOMPANSE SIROTIK OLGULARDA 3D TEDAVISININUZUN DÖNEM ETKINLIĞI

ALADAĞ M., HARPUTLUOĞLU M. M. M., BİLGİÇ Y., ÇAĞIN Y. F., KARINCAOĞLU M., SEÇKİN Y., et al.

34.ulusal gastroenteroloji haftası, Turkey, 1 - 06 December 2017, (Full Text)

31. Relationship between nucleotide-binding oligomerization doman-containing protein 2 variants an severity of acute pancretaitis

HARPUTLUOĞLU M. M. M., Özbek M., OTLU B., DEMİREL U., ALADAĞ M., ATAYAN Y., et al.

UEGW, 28 October - 01 November 2017, (Summary Text)

32. Relatıonshıp Between Nucleotide-Binding Oligomerization Domain-Containing Protein2 Variantsand Severıty of Acute Pancreatıtıs

HARPUTLUOĞLU M. M. M., ÖZBEK M., OTLU B., DEMİREL U., ALADAĞ M., ERDOĞAN M. A., et al.

25 th Unıted European Gastroenterology Week Barcelona 2017, Barcelona, Spain, 28 October - 01 November 2017, (Summary Text)

33. Relationship between Nucleotide-Binding Oligomerization Domain-Containing protein 2 varyants and severity of acute pancreatitis

HARPUTLUOĞLU M. M. M., özbek m., OTLU B., DEMİREL U., ALADAĞ M., ATAYAN Y., et al.

14.ULUSAL HEPATO GASTROENTEROLİ KONGRESİ, Turkey, 5 - 08 April 2017, (Full Text)

34. Relationship between Nucleotide-Binding Oligomerization Domain-Containg Protein 2 variants and severity of acute pancreatitis

HARPUTLUOĞLU M. M. M., ÖZBEK M., OTLU B., DEMİREL U., ALADAĞ M., ERDOĞAN M. A., et al.

14. ULUSAL HEPATO- GASTROENTEROLOJİ KONGRESİ, BARSELONA, Turkey, 5 - 08 April 2017, (Summary Text)

35. Relationship between Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants and severity of acute pancreatitis

HARPUTLUOĞLU M. M. M., ÖZBEK M., OTLU B., DEMİREL U., ALADAĞ M., ERDOĞAN M. A., et al.

1st Euroasian Gastroenterological Association Symposium, Antalya, Turkey, 5 - 08 April 2017, (Full Text)